The CanAct® C reports and assays offer single gene cancer reports that are commonly having known or emerging associations with tumor development and behavior in different cancer types. The CanAct® C reports and assays are available for liquid and solid tumor samples.
CanActgx ® by Product
Available for both solid tumor and liquid biopsies, the CanActgx ® choice of reports includes
Solid tumor & Liquid Biopsy
CanAct CKRAS
CanAct CNRAS
CanAct CEGFR
CanAct CEGFR+
CanAct CBRAF
CanAct CPIK
Solid tumor
CanAct CThr
CanAct CThr-F
CanAct CRNA
CanAct CMSI
CanAct CNTRK
CanAct CIDH
Blood/bone marrow
CanAct CIDH
CanAct CDPYD
CanAct CUGT
The CanAct® S reports and assays offer multiple gene cancer reports that are commonly having known or emerging associations specific cancers like Lung and Colon. The CanAct® S reports and assays are available for liquid and solid tumor samples.
Solid Tumor
CanAct SCLN
CanAct SLNG
Liquid Biopsy
CanAct SCLN
CanAct SLNG
Peripheral Blood
CanAct SPGX
The CanAct® X reports and assays offer comprehensive highly multiplex gene panels that are involved in most cancers in addition the CanAct® X reports cover other cancer genetic attributes like microsatellite instability and tumor mutational burden. The CanAct® X reports and assays are available for liquid and solid tumor samples.
Solid tumor
CanAct X5.0
Liquid Biopsy